2022
The bidirectional association of nonalcoholic fatty liver disease with depression, bipolar disorder, and schizophrenia
Jawad MY, Meshkat S, Tabassum A, Mckenzie A, Di Vincenzo JD, Guo Z, Musavi NB, Phan L, Ceban F, Kwan AT, Ramachandra R, Le GH, Mansur RB, Rosenblat JD, Ho R, Rhee TG, McIntyre RS. The bidirectional association of nonalcoholic fatty liver disease with depression, bipolar disorder, and schizophrenia. CNS Spectrums 2022, 28: 541-560. PMID: 36268655, DOI: 10.1017/s1092852922001043.Peer-Reviewed Original ResearchNonalcoholic fatty liver diseaseFatty liver diseasePsychiatric disordersMood disordersLiver diseaseDevelopment of NAFLDAssociation of NAFLDBipolar disorderAdrenal axis dysregulationLong-term treatmentMetabolic inflammatory diseasesQuality of lifeSelect patientsMetabolic syndromeAxis dysregulationClinical manifestationsPoor outcomeRegular screeningHolistic carePatientsDisordersBidirectional associationsDiseaseClinical derivativesBetter diagnosisCardiometabolic disorders, inflammation and the incidence of non-alcoholic fatty liver disease: A longitudinal study comparing lean and non-lean individuals
Aneni E, Saeed G, Bittencourt M, Cainzos-Achirica M, Osondu C, Budoff M, Parise E, Santos R, Nasir K. Cardiometabolic disorders, inflammation and the incidence of non-alcoholic fatty liver disease: A longitudinal study comparing lean and non-lean individuals. PLOS ONE 2022, 17: e0266505. PMID: 35385529, PMCID: PMC8985996, DOI: 10.1371/journal.pone.0266505.Peer-Reviewed Original ResearchConceptsNon-alcoholic fatty liver diseaseRisk of NAFLDElevated blood glucoseElevated blood pressureFatty liver diseaseBlood glucoseLean individualsBlood pressureCardiometabolic disordersPhysical inactivityWaist circumferenceLiver diseaseDevelopment of NAFLDHigh-sensitivity C-reactive proteinCardiovascular disease risk stratificationSensitivity C-reactive proteinCardiometabolic risk factorsAlcohol Use Disorders Identification TestC-reactive proteinMain exposure variableDisease risk stratificationHospital Israelita Albert EinsteinDisorders Identification TestAppropriate preventive measuresAtherogenic dyslipidemia
2020
Non‐alcoholic Fatty Liver Disease and Insulin Resistance
Petersen M, Samuel V, Petersen K, Shulman G. Non‐alcoholic Fatty Liver Disease and Insulin Resistance. 2020, 455-471. DOI: 10.1002/9781119436812.ch37.Peer-Reviewed Original ResearchNon-alcoholic fatty liver diseaseHepatic insulin resistanceFatty liver diseaseInsulin resistanceLiver diseaseDevelopment of NAFLDLipid-induced muscle insulin resistanceRandle glucose-fatty acid cycleCommon chronic liver diseaseType 2 diabetes mellitusHyperinsulinemic-euglycemic clamp studiesGlucose-fatty acid cycleLiver-related deathSkeletal muscleChronic liver diseaseNon-alcoholic steatohepatitisMajor risk factorLipid-induced hepatic insulin resistanceMuscle insulin resistanceDiabetes mellitusRisk factorsClamp studiesLipoprotein lipaseDiseaseProtein kinase C
2017
Non-alcoholic fatty liver disease: An expanded review
Benedict M, Zhang X. Non-alcoholic fatty liver disease: An expanded review. World Journal Of Hepatology 2017, 9: 715-732. PMID: 28652891, PMCID: PMC5468341, DOI: 10.4254/wjh.v9.i16.715.Peer-Reviewed Original ResearchNon-alcoholic fatty liver diseaseNAFLD patientsInsulin resistanceRisk factorsDevelopment of NAFLDTreatment of NAFLDFatty liver diseaseMedications/supplementsNumerous risk factorsNAFLD epidemiologyLiver transplantationCardiovascular mortalityLiver biopsySimple steatosisLiver diseaseMetabolic derangementsAssociated hepatitisDefinitive diagnosisPathologic changesFree fatty acidsAdvanced imagingLiver accumulationNatural historyProgressive steatosisGold standard
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply